Physician profile
Jack Wu
NPI 1457512584
$1,034.36
in general payments reported to CMS, 2019-2025
15 companies · $163 in 2025
The $163 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $701 · 2020: $109 · 2023: $27.70 · 2024: $32.96 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $224.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $224.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $337.02 | 2019-2020 | |
| Abbvie INC. | $135.74 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $131.74 | 2019 | |
| Sunovion Pharmaceuticals INC. | $60.97 | 2019 | |
| Neurocrine Biosciences, INC. | $48.26 | 2019-2023 | Ingrezza |
| Teva Pharmaceuticals USA, INC. | $43.79 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $40.98 | 2019 | |
| Arbor Pharmaceuticals, INC. | $38.77 | 2020 | |
| Janssen Pharmaceuticals, INC | $36.54 | 2019 | |
| Corium, LLC | $32.96 | 2024 | Azstarys |
| Lundbeck LLC | $28.59 | 2019 | |
| Axsome Therapeutics, INC. | $27.65 | 2025 | Auvelity |
| Neuronetics, INC. | $27.06 | 2019 | |
| Bausch Health US, LLC | $23.98 | 2020 | |
| Glaxosmithkline, LLC. | $20.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Wu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.